Angela Marini

Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule

Lynn G. Feun, Manuel Modiano, King Lee et al. · Cancer Chemotherapy and Pharmacology · 2002 · 118 citations

Medicine, Pharmacokinetics, Pharmacology +7

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Lynn G. Feun, Angela Marini, Gail Walker et al. · British Journal of Cancer · 2012 · 113 citations · Full text

Medicine, Clinical Sciences, Oncology +15

A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

Lynn G. Feun, Niramol Savaraj, Judith Hurley et al. · Cancer · 2000 · 25 citations

Medicine, Oncology, Pharmacology +11

Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors

Lynn G. Feun, Angela Marini, Howard J. Landy et al. · Journal of Neuro-Oncology · 2006 · 16 citations

Medicine, Neurology, Oncology +12

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

Lynn G. Feun, Christopher O’Brien, Enrique Molina et al. · Journal of Cancer Research and Clinical Oncology · 2003 · 13 citations · Full text

Medicine, Oncology, Pharmacology +10